Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference

Chemed Corporation (NYSE: CHE), headquartered in Cincinnati, Ohio, is scheduled to present virtually at the Oppenheimer 36th Annual Healthcare Conference on March 19, 2026, at approximately 9:20 a.m. Eastern Time. The virtual presentation will be accessible through Chemed’s Investor Relations page on its official website, www.chemed.com, where interested parties can also find the presentation materials. A replay of the webcast will be available within 24 hours post-presentation, remaining online for a period of 90 days.

Chemed operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare is recognized as the largest provider of hospice care in the United States, delivering critical end-of-life services to patients and their families with compassion and dignity. On the other hand, Roto-Rooter stands out as the leading provider of plumbing and drain cleaning services nationwide, catering to both residential and commercial customers with a broad range of plumbing solutions.

In its communications, Chemed may include forward-looking statements regarding future events or performance, which are made based on the information available about the company's current circumstances. Investors are advised to consider the risks associated with such statements, noting that actual results may differ materially due to unforeseen events or changes in expectations. Chemed explicitly disclaims any obligation to update its forward-looking statements in light of evolving circumstances.

For further inquiries, investors and interested that have di­rected public relations questions are encouraged to reach out to Michael D. Witzeman at 513-762-6714.

Chemed Corporation (NYSE: CHE), a unique player in the healthcare and plumbing sectors due to its dual business model, presents an intriguing opportunity for investors, especially with the upcoming virtual presentation at the Oppenheimer 36th Annual Healthcare Conference on March 19, 2026. This event not only showcases their strategic direction but also gives a platform for management to emphasize growth and innovation.

VITAS Healthcare, Chemed’s subsidiary, is the largest provider of hospice care in the U.S., positioning the company to benefit from the expanding healthcare needs of an aging population. As the demand for end-of-life care continues to grow, Chemed’s commitment to quality and accessibility should resonate well with investors focused on ESG (Environmental, Social, and Governance) criteria, particularly in health services.

On the other side, Roto-Rooter contributes consistent revenue through its plumbing services, which remain essential regardless of economic conditions. The stable cash flow generated from this subsidiary supports Chemed’s overall financial health and provides a cushion against fluctuations in the healthcare market.

As we approach the March presentation, investors should closely monitor key indicators such as patient admission rates at VITAS, legislative changes affecting hospice care reimbursement, and operational efficiency at Roto-Rooter. Listening to management’s insights during the conference could provide clarity on Chemed’s strategic initiatives going forward.

Given Chemed's strong performance history and dual revenue streams, it remains a compelling choice for investors seeking long-term growth with a diversified risk profile. However, it’s crucial to keep an eye on market conditions and regulatory changes affecting both sectors. Thus, position holdings accordingly, balancing potential growth with inherent risks acknowledged in Chemed’s communication.